BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: A$0.02 M
• Last 3 months FTD volume: A$0.58 M
• Last 12 months FTD volume: A$4.51 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	A$0.92 M	A$16.71 M	🇺🇸 USA
Sarepta Therapeutics SRPT	A$2.3 M	A$22.38 M	🇺🇸 USA
NanoViricides NNVC	A$1.96 M	A$6.74 M	🇺🇸 USA
Novavax NVAX	A$15.95 M	A$65.06 M	🇺🇸 USA
Gilead Sciences GILD	A$60.15 M	A$0.26 B	🇺🇸 USA
Celldex Therapeutics CLDX	A$7.65 M	A$11.96 M	🇺🇸 USA
GlaxoSmithKline GSK	A$72.01 M	A$0.40 B	🇬🇧 UK
Emergent BioSolutions EBS	A$1.89 M	A$4.32 M	🇺🇸 USA
Cel-Sci CVM	N/A	A$0.94 M	🇺🇸 USA